Drug intelligence / Profile preview

Acfree

Development stage: Unknown
Lead developer: Surecare Pharma
Modality: Small Molecules
Administration: Topical

Overview

Acfree is a topical over-the-counter (OTC) skincare product line developed by Surecare Pharma for the management of acne. The product range includes a gentle skin cleanser and a soap formulation designed to be non-comedogenic and suitable for dry, sensitive, and compromised skin. Marketed as a cosmeceutical solution, Acfree is intended for topical application to help maintain skin hygiene and manage acne-prone skin. Surecare Pharma, based in New Delhi, India, focuses on commercial dermatological solutions rather than clinical-stage drug development, and the Acfree line is part of their established commercial portfolio.

Brand names: Acfree

Targets

RARA (Retinoic acid receptor alpha)Bacterial 50S ribosomal subunit

Beyond the preview

Go deeper on Acfree.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acfree.

Explore the full profile